查詢結果分析
相關文獻
- Establishing a Cost Estimation Model for Hypertension and Its Related Diseases in Taiwan
- 臺灣省推行糖尿病、高血壓社區篩檢工作之成本分析
- 老年慢性阻塞性肺部疾病病患之高血壓用藥
- 基層用藥個案討論--Pentoxifylline[腦血管疾病] & Amlodipine[高血壓]
- 重症患者高血壓急症之治療
- Molecular Epidemiologic Study of Mitochondrial DNA Mutations in patients with Mitochondrial Diseases in Taiwan
- 未成年人的心血管疾病危險因子探討
- 慢跑者和無規律運動者心血管疾病盛行率之比較研究
- 源於內分泌疾病的高血壓
- 高血壓防治的最新發展--JNC 7簡介
頁籤選單縮合
題 名 | Establishing a Cost Estimation Model for Hypertension and Its Related Diseases in Taiwan=臺灣地區高血壓及其相關疾病之成本推估模型建構 |
---|---|
作 者 | 楊銘欽; 黃一展; | 書刊名 | 臺灣醫學會雜誌 |
卷 期 | 98:6 1999.06[民88.06] |
頁 次 | 頁394-402 |
分類號 | 419.45 |
關鍵詞 | 臺灣地區; 高血壓; 疾病; 成本推估模型; Cost of illness; Economic cost; Hypertension; Policy making; Population attributable risk proportion; |
語 文 | 英文(English) |
英文摘要 | Chronic diseases are responsible for significant economic losses related to direct costs of medical care, as well as indirect costs arising from lost productivity. To optimize the use of limited health care resources, there is a need to establish a comprehensive index to establish the priorities for funding of health programs for chronic diseases. In this study, we applied the population attributable risk proportion (PAR) model to estimate the economic burden imposed by hypertension and its related diseases in Taiwan in 1991. Data were collected from published statistical reports and research reports. The estimated total economic cost of hypertension and associated diseases was 9.0 to 11.9 billion New Taiwan dollars (NTD) in 1991 (1 US dollar was equivalent to 27 NTD in 1991). Direct costs were the largest component of total expenditure (5.4-7.1 billion NTD), followed by morbidity costs (3.2 billion NTD), and mortality costs (0.4.-1.5 billion NTD). Categorized by disease type, hypertensive diseases accounted for the largest share of costs (6.8-7.7 billion NTD), followed by cerebrovascular diseases (1.0-1.9 billion NTD). Disorders of arteries, arterioles, and capillaries accounted for the smallest share (41 million to 1 billion NTD). The method used in this study provides a satisfactory estimation of the economic burden imposed by hypertension and related diseases, and can be applied to other risk factors or diseases to show their separate economic impacts. The precision of such estimates can be greatly improved if health authorities establish more complete databanks to collect data on national expenditure for all types of health care services. This would, in turn, provide policy makers with more accurate data on which to base allocation of funding for chronic disease health care programs. |
本系統中英文摘要資訊取自各篇刊載內容。